Edition:
United States

Novus Therapeutics Inc (NVUS.OQ)

NVUS.OQ on NASDAQ Stock Exchange Capital Market

2.76USD
3:59pm EST
Change (% chg)

$0.01 (+0.36%)
Prev Close
$2.75
Open
$2.77
Day's High
$2.82
Day's Low
$2.76
Volume
2,757
Avg. Vol
22,394
52-wk High
$8.61
52-wk Low
$2.64

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.371
Jun '18 0.00 -0.339
Mar '18 0.00 -0.362
FY 2017 Dec '17 0.00 -0.294
Sep '17 0.00 -0.428
Jun '17 0.00 -1.603
Mar '17 0.00 -0.428
FY 2016 Dec '16 0.00 -1.485
Sep '16 0.00 -3.686
Jun '16 0.00 -5.378
Mar '16 0.00 -4.545
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 2 0.00 0.00 0.00 --
Quarter Ending Mar-19 2 0.00 0.00 0.00 --
Year Ending Dec-18 2 0.00 0.00 0.00 --
Year Ending Dec-19 2 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Dec-18 2 -0.40 -0.38 -0.42 --
Quarter Ending Mar-19 2 -0.40 -0.38 -0.41 --
Year Ending Dec-18 2 -1.47 -1.45 -1.49 --
Year Ending Dec-19 2 -1.41 -1.23 -1.59 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.45 30.88
P/E High - Last 5 Yrs. -- 41.60 46.69
P/E Low - Last 5 Yrs. -- 25.00 25.78
Beta 0.65 0.98 0.95
Price to Sales (TTM) -- 19.89 21.76
Price to Book (MRQ) 1.96 4.30 4.53
Price to Tangible Book (MRQ) 2.18 12.11 11.76
Price to Cash Flow (TTM) -- 21.70 22.24
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.68 1.60
Dividend Yield - 5 Year Avg -- 1.49 1.42
Dividend 5 Year Growth Rate -- -11.45 -8.76
Payout Ratio(TTM) -- 46.02 44.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 4.36 6.54
Sales (TTM) vs TTM 1 Yr. Ago -- 3.97 5.26
Sales - 5 Yr. Growth Rate -- 7.07 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago 13.24 22.48 22.50
EPS (TTM) vs TTM 1 Yr. Ago 65.36 -- --
EPS - 5 Yr. Growth Rate -- 6.71 7.64
Capital Spending - 5 Yr. Growth Rate -- 8.06 8.38

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.65 2.63
Current Ratio (MRQ) 10.67 3.71 3.68
LT Debt to Equity (MRQ) 0.00 7.50 9.53
Total Debt to Equity (MRQ) 0.00 10.94 13.39
Interest Coverage (TTM) -- 40.82 33.85

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 51.06 50.91
Gross Margin - 5 Yr. Avg. -- 52.20 52.22
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.43 16.27
Operating Margin (TTM) -- 8.35 -15.11
Operating Margin - 5 Yr. Avg. -- 14.50 11.89
Pre-Tax Margin (TTM) -- 8.99 -13.67
Pre-Tax Margin - 5 Yr. Avg. -- 14.91 12.22
Net Profit Margin (TTM) -- 5.44 -17.11
Net Profit Margin - 5 Yr. Avg. -- 11.12 8.44
Effective Tax Rate (TTM) -- 21.91 21.73
Effective Tax Rate - 5 Yr. Avg. -- 23.94 24.41

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 989,839,630 878,349,382
Net Income/Employee (TTM) -- 115,653,467 102,474,711
Receivable Turnover (TTM) -- 5.43 5.49
Inventory Turnover (TTM) -- 2.74 3.99
Asset Turnover (TTM) 0.00 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -54.02 11.53 11.06
Return on Assets - 5 Yr. Avg. -53.18 12.44 11.85
Return on Investment (TTM) -59.43 14.34 13.80
Return on Investment - 5 Yr. Avg. -57.03 15.95 15.17
Return on Equity (TTM) -59.58 15.85 15.29
Return on Equity - 5 Yr. Avg. -106.86 16.93 16.29
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 81.42 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Novus Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 52.90%
# of Holders: 32
Total Shares Held: 4,984,024
3 Mo. Net Change: 3,093
# New Positions: 6
# Closed Positions: 2
# Increased Positions: 15
# Reduced Positions: 7
# Net Buyers: 8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.